Open access
Open access
Powered by Google Translator Translator

Endocrinology (all articles)

ADA Consensus Report: The Management of Type 1 Diabetes in Adults.

3 Oct, 2021 | 22:38h | UTC

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) – Diabetologia

News release: New comprehensive Consensus Report to manage type 1 diabetes launched by major diabetes organisations EASD and ADA – American Associatio of Diabetes

Related: Guideline: ADA 2021 Standards of Medical Care in Diabetes

 

Commentary on Twitter

 

Ketogenic diets in the management of type 1 diabetes: Safe or safety concern?

3 Oct, 2021 | 22:28h | UTC

Ketogenic diets in the management of type 1 diabetes: Safe or safety concern? – Cleveland Clinic Journal of Medicine

 

Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis.

1 Oct, 2021 | 10:17h | UTC

Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis – PLOS Medicine

Commentaries:

Sticking to low-fat dairy may not be the only heart healthy option, study shows – George Institute for Global Health

Expert reaction to cohort study and review on biomarkers of dairy fat intake, CVD and all-cause mortality – Science Media Centre

People who eat more dairy fat have lower risk of heart disease, study suggests – CNN

 

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

1 Oct, 2021 | 10:19h | UTC

Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)

 

Commentary on Twitter

https://twitter.com/LancetGastroHep/status/1440164633805918224

 

Total dietary fat intake, fat quality, and health outcomes: A scoping review of systematic reviews of prospective studies.

1 Oct, 2021 | 10:16h | UTC

Total Dietary Fat Intake, Fat Quality, and Health Outcomes: A Scoping Review of Systematic Reviews of Prospective Studies – Annals of Nutrition and Metabolism

 

RCT: A structured program of diet and exercise significantly reduced blood pressure and cardiovascular disease biomarkers in patients with resistant hypertension.

30 Sep, 2021 | 10:14h | UTC

Effects of Lifestyle Modification on Patients With Resistant Hypertension: Results of the TRIUMPH Randomized Clinical Trial – Circulation

News release: Healthy changes in diet, activity improved treatment-resistant high blood pressure – American Heart Association

 

Commentary on Twitter

 

Podcast: Diabetic Pearls.

28 Sep, 2021 | 08:53h | UTC

#296 Diabetes FAQ with Dr. Jeff Colburn – The Curbsiders

 

Interactive Infographic: Milestones in diabetes.

28 Sep, 2021 | 08:58h | UTC

Milestones in diabetes – Nature

 

Review | Interplay between endocrinology, metabolism, and COVID-19 infection.

24 Sep, 2021 | 10:00h | UTC

Interplay between endocrinology, metabolism, and COVID-19 infection – Clinical Medicine Journal

 

Cohort Study: Insulin resistance linked to increased risk of major depressive disorder.

24 Sep, 2021 | 08:59h | UTC

Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study – The American Journal of Psychiatry

Commentaries:

Insulin Levels, BMI in Youth May Be Linked to Psychosis, Depression Risk in Adulthood – Psychiatric News

Insulin Resistance Linked to Major Depressive Disorder, Dutch Study Finds – Psychiatric News Alert

Insulin resistance doubles risk of major depressive disorder – Stanford Medicine

 

AHA Scientific Statement: Weight-loss strategies for prevention and treatment of hypertension.

22 Sep, 2021 | 10:09h | UTC

Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association – Hypertension

News release: Weight-loss meds, surgery could fight obesity-related high blood pressure – American Heart Association

 

Side effect patterns in a crossover trial of statin, placebo, and no treatment – This N-of-1 trial, now published in full, suggests the nocebo effect causes most of statins muscle adverse effects.

19 Sep, 2021 | 23:30h | UTC

Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment – Journal of the American College of Cardiology

See also: #AHA20 – In patients who had discontinued statins because of side effects, a N-of-1 trial of a statin, placebo, or no treatment found that side effects often attributed to statins were the same for those taking a placebo

 

Non-alcoholic fatty liver disease: A patient guideline.

19 Sep, 2021 | 23:35h | UTC

Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports

 

Commentary on Twitter

 

Editorial | Insulin for all: a hope yet to be realized.

16 Sep, 2021 | 09:59h | UTC

Insulin for all: a hope yet to be realized – The Lancet Diabetes & Endocrinology

Related: One hundred years of insulin therapy.

 

Commentary on Twitter

 

Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021.

14 Sep, 2021 | 08:57h | UTC

Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021 – Canadian Journal of Diabetes

 

The carbohydrate-insulin model: a physiological perspective on the obesity pandemic.

14 Sep, 2021 | 08:53h | UTC

The carbohydrate-insulin model: a physiological perspective on the obesity pandemic – American Journal of Clinical Nutrition

News release: Scientists claim that overeating is not the primary cause of obesity – American Society for nutrition

 

Commentary on Twitter (thread – click for more)

 

One hundred years of insulin therapy.

14 Sep, 2021 | 08:52h | UTC

One hundred years of insulin therapy – Nature Reviews Endocrinology

 

Commentary on Twitter

 

Different risks and benefits leading to similar costs after sleeve gastrectomy and Roux-en-Y gastric bypass.

12 Sep, 2021 | 21:37h | UTC

Commentary: Different Risks and Benefits Leading to Similar Costs After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass – JAMA Network Open

Original study: Comparison of 4-Year Health Care Expenditures Associated With Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy – JAMA Network Open

 

Commentary on Twitter

 

Systematic review: evaluation of dietary patterns and all-cause mortality.

6 Sep, 2021 | 10:43h | UTC

Evaluation of Dietary Patterns and All-Cause Mortality: A Systematic Review – JAMA Network Open

 

Commentary on Twitter (thread – click for more)

 

Study shows young children gained weight during the pandemic.

31 Aug, 2021 | 08:59h | UTC

News release: Young children gained weight during the pandemic – Kaiser Permanente

Original study: Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic – JAMA

 

Commentary on Twitter

 

#ESCCongress – 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

31 Aug, 2021 | 08:53h | UTC

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC) – European Heart Journal

News release: How can I avoid heart disease or stroke? – European Society of Cardiology

Key Points: 2021 ESC Guidelines on CVD Prevention in Clinical Practice – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – M-A: Polypills with and without aspirin substantially reduce cardiovascular disease, myocardial infarction, stroke, revascularization, and cardiovascular death in primary cardiovascular disease prevention.

31 Aug, 2021 | 08:47h | UTC

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis – The Lancet (link to abstract – $ for full-text)

Commentary: Combo therapy cuts risk of heart attacks and strokes in half – McMaster University

Related:

Opinion: A new important study supports wider use of the polypill

#AHA20 – Randomized trial: A polypill comprising statins, multiple blood pressure lowering drugs, and aspirin prevents cardiovascular events among patients at intermediate cardiovascular risk

Perspective: Are Polypills and Population-based Treatment the Next Big Things?

The Polypill Revisited: Why We Still Need Population-Based Approaches in the Precision Medicine Era

Randomized Trial: Polypill for Cardiovascular Disease Prevention in an Underserved Population

Randomized Trial: Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases

Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology – Global Heart

Perspective: The Polypill and the Long Journey to Major Impact

Research: Low-Dose ‘Triple Pill’ Lowers Blood Pressure More Than Usual Care

 

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes – An HbA1c < 6.5% measured at least 3 months after cessation of glucose-lowering pharmacotherapy is suggested as the usual diagnostic criteria.

31 Aug, 2021 | 08:45h | UTC

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes – The Journal of Clinical Endocrinology & Metabolism

News release: International Experts Outline Diabetes Remission Diagnosis Criteria – Endocrine Society

 

#ESCCongress – RCT: SGLT2 inhibition reduced the combined risk of cardiovascular death or hospitalization in patients with heart failure and a preserved ejection fraction, regardless of the presence or absence of diabetes.

29 Aug, 2021 | 18:19h | UTC

Empagliflozin in Heart Failure with a Preserved Ejection Fraction – New England Journal of Medicine

News release: Trial reports first successful results for heart failure with preserved ejection fraction – European Society of Cardiology

Commentary: Empagliflozin Outcome Trial in Patients With Chronic Heart Failure With Preserved Ejection Fraction – EMPEROR-Preserved – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – RCT: Finerenone reduced CV events in patients with kidney disease and type 2 diabetes (12.4% vs. 14.2% during a median follow-up of 3.4 years), but the risk of hyperkalemia was increased (10.8% vs. 5.3%).

29 Aug, 2021 | 18:14h | UTC

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes – New England Journal of Medicine

News release: Finerenone benefits patients with diabetes across spectrum of kidney disease – European Society of Cardiology

Commentaries:

Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease – FIGARO-DKD – American College of Cardiology

FIGARO-DKD and FIDELITY Findings Show Benefits of Finerenone to Improve Outcomes in Patients With Kidney Disease, Diabetes – American College of Cardiology

Related:

[Abstract Only] Randomized trial: Effect of Finerenone on chronic kidney disease outcomes in Type 2 diabetes

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.